Literature DB >> 360304

PGE2 is a more potent vasodilator of the lamb ductus arteriosus than is either PGI2 or 6 keto PGF1alpha.

R I Clyman, F Mauray, C Roman, A M Rudolph.   

Abstract

It has been shown in vitro that the lamb ductus arteriosus forms prostaglandins PGE2, PGF2alpha, 6 keto PGF1alpha (and its unstable precursor PGI2). In this study the relative potencies of these endogenous prostaglandins were investigated on isolated lamb ductus arteriosus preparations contracted by exposure to elevated PO2 and indomethacin. All the prostaglandins (except PGF2alpha) relaxed the vessel. This is consistent with the hypothesis that endogenous prostaglandins inhibit the tendency of the vessel to contract in response to oxygen. Only PGE2, however, relaxed the vessel at concentrations below 10(-8)M. PGI2 and 6 keto PGF1alpha had approximately 0.001 and 0.0001 times the activity of PGE2. Although PGE2 has been observed to be a minor product of prostaglandin production in the lamb ductus arteriosus, the tissue's marked sensitivity to PGE2 might make it the most significant prostaglandin in regulating the patency of the vessel.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 360304     DOI: 10.1016/0090-6980(78)90028-x

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  13 in total

1.  Redox control of oxygen sensing in the rabbit ductus arteriosus.

Authors:  H L Reeve; S Tolarova; D P Nelson; S Archer; E K Weir
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

2.  Distribution of prostacyclin synthase, 6-keto-prostaglandin F1 alpha, and 15-hydroxy-prostaglandin dehydrogenase in the normal and persistent ductus arteriosus of the dog.

Authors:  E G de Reeder; A C Gittenberger-de Groot; J C van Munsteren; R E Poelmann; D F Patterson; M J Keirse
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

3.  Endogenous dilator prostaglandins in congenital heart disease.

Authors:  C Hammerman; M J Aramburo; K C Bui
Journal:  Pediatr Cardiol       Date:  1987       Impact factor: 1.655

4.  Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus.

Authors:  H W Seyberth; G Knapp; D Wolf; H E Ulmer
Journal:  Eur J Pediatr       Date:  1983-12       Impact factor: 3.183

5.  Development of a high-affinity inhibitor of the prostaglandin transporter.

Authors:  Yuling Chi; Jaeki Min; Jean-Francois Jasmin; Michael P Lisanti; Young-Tae Chang; Victor L Schuster
Journal:  J Pharmacol Exp Ther       Date:  2011-08-17       Impact factor: 4.030

6.  Interactions between indomethacin, noradrenaline and vasodilators in the fetal rabbit ductus arteriosus.

Authors:  G C Smith; J C McGrath
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice.

Authors:  Hee-Yoon Chang; Joseph Locker; Run Lu; Victor L Schuster
Journal:  Circulation       Date:  2010-01-18       Impact factor: 29.690

8.  Early administration of indomethacin to preterm infants.

Authors:  J M Rennie; J Doyle; R W Cooke
Journal:  Arch Dis Child       Date:  1986-03       Impact factor: 3.791

9.  Prostaglandin levels: predictors of indomethacin responsiveness.

Authors:  C Hammerman; W Zaia; S Berger; E Strates; A Aldousany
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

Review 10.  Role of endothelin in uteroplacental circulation and fetal vascular function.

Authors:  Alexandra Paradis; Lubo Zhang
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.